# Eurazeo account plan

> Eurazeo is a European private markets asset manager with €40,067 million of AUM at June 30, 2026, across private equity, private debt and real assets.

## At a glance

Eurazeo describes itself as an integrated asset management platform for private markets, investing institutional, retail and its own balance sheet capital in European mid-market, growth and impact companies. It earns management and performance fees and the value created on its own capital invested in Group funds, with offices including Paris, London, Frankfurt, Berlin, Milan, Luxembourg and Stockholm. AUM was €38,968 million at December 31, 2025, of which €30,097 million third-party. In 2025 management fees were €435 million, asset management EBITDA €206 million and net income attributable to owners -€403 million. The workforce excluding iMGP was 451 full-time employees at mid-2026; the David-Weill family and JCDecaux Holding SAS are main shareholders.

## Business units

- **Private Debt** (AUM €11,197 million at end-2025 (about 29%, computed)): Direct lending to sponsor-backed European mid-market companies, plus asset-based finance and Flex Financing for sponsorless SMEs. Over €2.5 billion was invested in 2025, and EPD VII reached a €3.9 billion final close, above its €3.0 billion target. Managing Partners: François Lacoste and Eric Gallerne.
- **Buyout: Capital** (AUM €7,133 million at end-2025 (about 18%, computed)): Backs established mid-caps scaling internationally in tech-enabled business services, healthcare and financial services. Eurazeo Capital V closed at about €3 billion; 2025 exits included Albingia and CPK. Co-heads: Maxime de Bentzmann and Eric Sondag.
- **Secondaries & Mandates** (AUM €6,452 million at end-2025 (about 17%, computed)): Access to European mid-market buyout through primary commitments, secondaries and co-investments; nearly €1 billion deployed across 18 secondary transactions in 2025, and ESF V closed at €2.3 billion. Managing Partner: Christophe Simon.
- **Growth** (AUM €3,729 million at end-2025 (about 10%, computed)): Backs technology-driven scale-ups expanding internationally; Eurazeo Growth Fund IV had a first closing at €650 million and Cognigy was sold to NICE. Managing Partner: Hala Fadel.
- **Buyout: Elevate** (AUM €3,476 million at end-2025 (about 9%, computed)): Supports European lower mid-market companies becoming mid-caps; its portfolio created +14% value in 2025, and Eurazeo PME V had a first close above €1 billion. Led by Pierre Meignen.
- **Venture and Kurma Partners** (AUM €2,806 million (Venture) and €625 million (Kurma) at end-2025): Venture covers Digital and Future Industries; Kurma Partners, fully owned since 2025, is the healthcare and biotech venture team, which sold ImCheck and Memo Therapeutics to Ipsen. Matthieu Baret is Managing Partner, Venture.
- **Real Assets** (AUM €2,057 million at end-2025 (about 5%, computed)): Infrastructure focused on decarbonisation of essential services, and real estate operating platforms in hospitality, healthcare, managed residences, self-storage and data centers. Portfolio value fell 10% in 2025 on real estate capitalisation rates.
- **Brands, Nov Santé and Planetary Boundaries** (AUM €576 million, €383 million and €373 million at end-2025): A consumer brands portfolio in the US and Europe, the Nov Santé healthcare fund, and the EPBF impact buyout fund launched in May 2024 with first investments in Bioline AgroSciences and SMP Energies.
- **Eurazeo Wealth Solutions** (AUM €6.0 billion at June 30, 2026): Distributes private markets funds to individual investors via evergreen funds, feeders and ELTIF structures, expanding in Belgium, Germany, Switzerland and Italy. Headed by Luc Maruenda.
- **iM Global Partner (iMGP)** (Third-party management fees €85 million in 2025): Listed-asset management affiliate; fees were muted by volatile public markets in 2025.

## Strategic priorities

- **2024-2027 strategic plan**: Presented on November 30, 2023, it aims to make Eurazeo the private asset management leader in Europe in mid-market, growth and impact; targets were confirmed in H1 2026.
- **Third-party fundraising**: Third-party fundraising reached €5.5 billion in 2025, with about 25% annual growth over three years and 71% of institutional flows from abroad.
- **Portfolio rotation**: Shift balance sheet capital to more capital-light models; about 20% of companies were sold in 2025, and significant exit volumes are expected in 2026.
- **International and retail distribution**: New Milan and Stockholm offices, and Wealth Solutions expanding outside France with two Luxembourg evergreen funds launched at end-2025.
- **Shareholder returns**: Dividend of €2.92 per share paid in 2026 (+10%), about 2% of capital bought back in H1 2026 and around €1.3 billion returned since early 2024.

## Latest results

In H1 2026 (to June 30), management fees were €213 million (+6% at constant forex), with third-party private markets fees up 18%. FRE rose 11% to €78 million (36.6% margin) and asset management EBITDA rose 20% to €100 million. AUM reached €40,067 million, with fundraising of €2,273 million led by private debt. The balance sheet portfolio's net value rose to €105.4 per share from €102.1, and net income Group share was -€6 million against a much larger loss a year earlier. The Group confirmed its Capital Markets Day targets and expects value creation to improve in 2026.

## Investments and deals

- **New fund closings**: EPD VII final close at €3.9 billion, ESF V at €2.3 billion, Eurazeo PME V first close above €1 billion and Kurma Biofund IV at €215 million in H1 2026.
- **Deployments**: €1,870 million deployed in H1 2026, including new companies Netco Group, Nextron Systems, Babylon, T1A Group and Lauralu.
- **Kurma Partners buyout**: Eurazeo bought the remaining 29.4% of Kurma Partners in 2025.
- **Financing**: An inaugural €500 million bond at 4.625% due April 2031, and a €480 million private debt continuation vehicle closed with Pantheon in February 2026.

## Challenges and risks

- **Legacy balance sheet value**: Investment activity contributed -€552 million in 2025; the Co-CEOs say some assets invested over 2015-2021 are still getting back on track.
- **Share price discount**: Total shareholder return was -22.7% in 2025; management says it is dissatisfied with a price well below its intrinsic value calculation.
- **Lengthening fundraising cycle**: The ability to raise funds in a lengthening fundraising cycle is a significant risk.
- **AI disruption of software**: AI disruption of software models is a named risk, with SaaS around 10% of AuM excluding Growth and Venture.
- **Currency and macro**: The US dollar's depreciation cost about €300 million in 2025, amid trade tensions and the Middle East conflict.

## What leadership says

> "moved from an investment holding company to an integrated asset management platform structured around its clients" — Jean-Charles Decaux, Chairman of the Supervisory Board, Universal Registration Document 2025, March 2026

> "For Eurazeo, the challenge is to maintain rigorous execution" — Christophe Bavière and William Kadouch-Chassaing, Co-CEOs, Universal Registration Document 2025, March 2026

> "our balance sheet portfolio is once again creating value" — Christophe Bavière and William Kadouch-Chassaing, Co-CEOs, Half-Year Financial Report 2026, July 2026

> "Now we are purely an asset manager" — William Kadouch-Chassaing, Co-CEO and Chairman of the Executive Board, Boursorama interview, June 1, 2026 (translated from French)


## Where a supplier can help

- **Investor relations and fundraising tooling**: Third-party fundraising growth, 31 new institutional LPs in H1 2026 and international flows create needs in LP reporting, CRM and data rooms.
- **Wealth distribution operations**: Wealth Solutions' expansion across Belgium, Germany, Switzerland and Italy with evergreen and ELTIF funds needs onboarding, compliance and fund administration support.
- **Portfolio value creation services**: With legacy assets to get back on track and significant exits planned in 2026, the portfolio's companies are a route for operational, digital and AI advisory offers.
- **Private debt operations**: Private debt growing to €11,842 million of AUM by mid-2026 favours loan administration, monitoring and risk tools.
- **Software due diligence**: The named AI disruption risk to software models opens room for technical and AI due-diligence providers.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Universal Registration Document 2025 (2025 Annual Financial Report)](https://www.eurazeo.com/sites/default/files/2026-04/Eurazeo_Universal_Registration_Document_2025_EN_260402_MEL.pdf)

Annual report · 2026-03-27

- Eurazeo is a Paris-listed private markets asset manager with €39.0 billion of assets under management at December 31, 2025 (up 8% over 12 months), of which €30,097 million third-party; it presents itself as having moved "from an investment holding company to an integrated asset management platform".
- Three areas: Private Equity (€25,715 million AUM: Buyout, Growth, Venture, Secondaries & Mandates), Private Debt (€11,197 million; "more than €10 billion" for the first time) and Real Assets (€2,057 million: Infrastructure, Real Estate); focus on the European mid-market, growth and impact.
- Record third-party fundraising of €5.5 billion in 2025 (+28% in a declining global market); 71% of institutional flows came from outside France and 17% of fundraising from retail clients (Wealth Solutions, nearly €6 billion AUM).
- Asset management: management fees €435 million (+3%), third-party fees €322 million; FRE €156 million (margin 35.9%); asset management EBITDA €206 million (+12%, margin 44%); PRE doubled to €33 million.
- Balance sheet: investment portfolio €6,821 million (€102.1 per share vs €107.8), fair value -€322 million (-4%), mostly forex (-€199 million); net loss attributable to owners -€403 million (2024: -€430 million).
- Asset rotation: balance sheet divestments of €1.5 billion (c. 20% of the end-2024 portfolio), including Albingia (2.2x, c. €325 million), CPK (c. €240 million), UPD (2.1x), Fermax (2.6x, IRR close to 40%), Cognigy and ImCheck (Kurma).
- Shareholder return: dividend €2.92 per share (+10%); €380 million of buybacks in 2025 (nearly 9% of shares); c. 4% of capital (around €200 million) in 2026 and c. 9% in 2027.
- Governance: Executive Board of Christophe Bavière and William Kadouch-Chassaing (Co-CEOs) plus Sophie Flak; from February 5, 2026 Kadouch-Chassaing chairs the Executive Board and Bavière is CEO; Jean-Charles Decaux chairs the Supervisory Board.
- Main risks: macro-economic environment, ability to raise funds, investment vetting (SaaS exposure outside Growth/Venture around 10% of AuM amid AI disruption fears), key personnel, competition, liquidity and forex.

### [Half-Year Financial Report 2026](https://www.eurazeo.com/sites/default/files/2026-08/Eurazeo-Rapport-Financier-Semestriel-Juin-2026-GB.pdf)

Interim report · 2026-07-23

- H1 2026 third-party fundraising €2.3 billion (+10%), driven by Private Debt (€1.5 billion, +73%); final closing of EPD VII at €3.9 billion (programme €5.5 billion) and first closing of Eurazeo PME V at over €1 billion.
- AUM €40 billion at June 30, 2026 (+9% over 12 months), third-party €31.1 billion (+13%); balance sheet AUM down to 22% of total (31% at end-2023); Fee Paying AUM €29.4 billion.
- Management fees €213 million (third-party €163 million, +14% excluding forex); FRE €78 million (+11%, margin 36.6%); asset management EBITDA €100 million (+20%, margin 44.7%).
- Balance sheet portfolio €6.9 billion, €105.4 per share (+3.3%), with organic value creation of +0.3% after several halves of valuation cuts.
- Net income Group share -€6 million vs -€311 million in H1 2025.
- Realizations €0.7 billion (Fermax 2.6x, Ex Nihilo 2.7x, Kurma's sale of Memo Therapeutics to Ipsen) and deployments €1.9 billion; dry powder around €6.6 billion.
- First senior bond: €500 million, 4.625%, maturing 2031, after BBB ratings from Fitch and S&P; consolidated net debt €1,493 million.
- About €320 million to be returned to shareholders in 2026; c. 9% further buybacks in 2027, around 25% cumulative over 2024-2027; 2023 Capital Markets Day targets confirmed.

### ["Eurazeo est une société qui combine croissance, transformation et très haut rendement" (Boursorama interview)](https://www.youtube.com/watch?v=Xad_A0HCRjU)

Executive talk · William Kadouch-Chassaing, Co-CEO and Chairman of the Executive Board · 2026-06-01

- William Kadouch-Chassaing, Co-CEO, on Boursorama's live "grande interview" (June 1, 2026, in French).
- Says fundraising has grown at double digits for three years, on average 22-23% a year in a flat market; Q1 2026 fundraising €1.1 billion vs €900 million a year earlier (+11%).
- Eurazeo is now "purely an asset manager" with a large balance sheet, focused on Europe and small and mid-sized companies.
- On private credit: European lower mid-market loans are structured far more safely than US deals; Eurazeo sees no rise in risk in its portfolios and very low defaults.
- Target is third-party AUM growth above the market (seen at around 7-8%); third-party AUM is over 70% of the total, +14% in Q1.
- Share price around €46-47 against an intrinsic value Eurazeo puts closer to €130; blames the sector de-rating and balance sheet value cuts of about 8% over 2024-2025.
- A separate listing of the asset manager and the balance sheet portfolio is studied but "premature".
- Pitch to investors: growth, transformation and high yield, with 12% of shares bought back in two years and dividend up 10% a year.

### ["Le plus gros risque c'est le manque de confiance de l'Europe en elle-même" (BFM Business interview)](https://www.youtube.com/watch?v=vFv0FJHcZp8)

Executive talk · Christophe Bavière, Co-CEO · 2026-03-18

- Christophe Bavière, Co-CEO, on BFM Business's morning show just after the FY2025 results (March 18, 2026, in French); the share had fallen 10% on results day.
- Says asset rotation returned to about 20% of the portfolio in 2025, back to historical averages, and 2025 exits were sold at 2.1x cost, always above book value; a pipeline of exits is being prepared for 2026.
- Acknowledges Eurazeo took "prudence measures" (provisions) on some companies in 2025.
- On software and AI: Eurazeo backs profitable, cash-generating European companies bought at "very reasonable" prices, unlike some US valuations.
- Private debt (about €10 billion AUM) is "buy and build" lending; average leverage on Eurazeo Private Debt VII is 4.1x EBITDA, with a very low default rate.
- Eurazeo can grow alone (€5.5 billion raised last year, AUM near €40 billion) but is open to combinations if a good opportunity arises.
- Biggest risk: "Europe's lack of confidence in itself"; welcomes the EU Inc status for start-ups.

## Questions about Eurazeo

### What does Eurazeo do?

Eurazeo manages private markets funds in private equity, private debt and real assets for institutional and retail investors and invests its own balance sheet alongside them, focused on European mid-market, growth and impact.

### How large is Eurazeo?

AUM was €40,067 million at June 30, 2026; 2025 management fees were €435 million and asset management EBITDA €206 million.

### Who leads Eurazeo?

Co-CEOs Christophe Bavière and William Kadouch-Chassaing lead the Executive Board; Jean-Charles Decaux chairs the Supervisory Board and Laurence Branthomme is CFO.

### How many employees does Eurazeo have?

The workforce excluding iMGP was 451 full-time employees at mid-2026.

### What is Eurazeo's strategy?

The 2024-2027 plan targets leadership in European private asset management through third-party fundraising, faster portfolio rotation, international expansion and retail distribution.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
